Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a collective group of **bacterial enzymes essential for DNA replication and protein synthesis**, including DNA polymerases, DNA gyrases, primases, RNA polymerases, and ribosomal components such as 30S and 50S subunits. These enzymes catalyze crucial steps in ensuring proper genome duplication and translation of genetic information into proteins, processes indispensable for bacterial survival and proliferation[3][7][2]. Many antibiotics exploit biochemical differences between bacterial and eukaryotic targets, selectively inhibiting these enzymes to treat infections[7][1]. However, the diversity and broad grouping in this entry mean it lacks a single, canonical target or molecular identity, and includes multiple families of bacterial enzymes. Consequently, it is not sufficiently specific to serve as a unique drug target entry, as each enzyme (e.g., DNA gyrase, 23S rRNA in the 50S subunit, RNA polymerase, etc.) represents a distinct, clinically relevant target[7][3][1]. **Note:** This entry covers a broad, unspecific category of targets rather than a single, well-defined protein or molecular target. For drug discovery or structured data, each bacterial enzyme involved in these pathways should be referenced individually (e.g., "DNA gyrase," "RNA polymerase," "23S ribosomal RNA," etc.).[7][3][1]
Inhibition of ribosomal subunits to block protein synthesis (30S, 50S subunit inhibitors) - Inhibition of DNA gyrase or topoisomerase to block DNA replication (quinolones) - Inhibition of RNA polymerase (rifamycins) - Inhibition of cell wall synthesis (for β-lactams; β-lactamase enzymes in bacteria can resist action)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial enzyme involved in DNA or protein synthesis.